| Website | eddingpharm.com |
| Category | BioTech |
| Phone | +(852) 6356 9567 |
| Employees |
| TOTAL | $24M |
| VENTURE FUNDING TOTAL | $24M |
| Series B, 9/10 OrbiMed Advisors Domain Associates Sequoia Capital | $24M |
Eddingpharm, headquartered in Shanghai, is a leading specialty pharmaceuticals company in the fast growing China market. The Company is focused on medical nutrition and oncology therapeutic areas and became a leading commercialization platform for pharmaceutical products in China. To date, Eddingpharm has been granted exclusive market rights of more than 16 products and achieved outstanding performance on marketed products through its 23 district offices reaching over 1000 hospitals in China. Eddingpharm has become the partner of choice for multiple global pharmaceutical companies and continues to expand further alliance opportunities with international partners. Additionally, the Company is currently building R&D and manufacturing capabilities through strategic alliances, enabling it to develop customized pipeline best fitted for Chinese healthcare market.
